TREMs define the threshold and duration of myeloid cell responses, both promoting and attenuating myeloid cell activation and differentiation. 1 To that end, TREMs have been implicated in numerous ...

AML is an aggressive blood cancer that originates in the bone marrow and is known to impair the differentiation of myeloid cells, which leads to overproduction of immature cells. The condition ...

ZIONSVILLE, INDIANA / ACCESS Newswire / April 2, 2025 / Jabez Biosciences, Inc., a clinical-stage biopharmaceutical company dedicated to ushering in the future of cancer therapy, today announced that ...

This study reveals that the expression of the Src-family kinase (SFK), FGR, alone can induce cell differentiation similar to RA."BUFFALO, NY – March ...

Sanofi and Dren Bio, Inc., a private clinical-stage biopharmaceutical company, have entered into a definitive agreement under which Sanofi has agreed to acquire DR-0201, a targeted bispecific myeloid ...